Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer

Histopathology

Volumn 71, Issue 6, 2017, Pages 866-873

  Holten Rossing, Henrik ^a   Talman, Maj Lis Møller ^a   Jylling, Anne Marie Bak ^b   Lænkholm, Anne Vibeke ^c   Kristensson, Martin ^d   Vainer, Ben ^a  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^d Visiopharm   (Denmark)

Author keywords

Breast cancer; image analysis; sentinel lymph node biopsy

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOMATION; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CANCER SCREENING; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPITHELIUM TUMOR; FEMALE; GOLD STANDARD; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LOBULAR CARCINOMA; LUMPECTOMY; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SIMPLE MASTECTOMY; TUMOR VOLUME; WORKLOAD; AXILLA; BREAST TUMOR; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; LABORATORY AUTOMATION; LYMPH NODE; MICROMETASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AUTOMATION, LABORATORY; AXILLA; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MIDDLE AGED; NEOPLASM MICROMETASTASIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; WORKLOAD;

EID: 85030170567     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.13305     Document Type: Article

References (19)

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int. J. Cancer. 2012; 2015; E359–E386.
2. Patani N, Mokbel K. Clinical significance of sentinel lymph node isolated tumour cells in breast cancer. Breast Cancer Res. Treat. 2011; 127; 325–334.
3. Maguire A, Brogi E. Sentinel lymph nodes for breast carcinoma: an update on current practice. Histopathology 2016; 68; 152–167.
4. Giuliano AE, Dale PS, Turner RR et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg. 1995; 222; 394–399; discussion 399–401.
5. Tvedskov TF, Jensen MB, Ejlertsen B et al. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study. Breast Cancer Res. Treat. 2015; 153; 599–606.
6. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res. Treat. 2011; 127; 195–203.
7. Schijven MP, Vingerhoets AJ, Rutten HJ et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur. J. Surg. Oncol. 2003; 29; 341–350.
8. Turner RR, Weaver DL, Cserni G et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J. Clin. Oncol. 2008; 26; 258–263.
9. van Diest PJ, van Deurzen CH, Cserni G. Pathology issues related to SN procedures and increased detection of micrometastases and isolated tumor cells. Breast. Dis. 2010; 31; 65–81.
10. Sobin LH, Gospodarowicz MK, Wittekind C et al. TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell, 2010.
11. Moller S, Jensen MB, Ejlertsen B et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta. Oncol. 2008; 47; 506–524.
12. Bjerre KDJM, Christiansen P. DBCG report 2014. www.dbcg.dk, 2014.
13. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J. Clin. Pathol. 2001; 54; 550–552.
14. DBCG. Anvendelse af sentinel node biopsi (Danish) [Sentinel node guidelines]. 2013. Available at: http://www.dbcg.dk/PDF%20Filer/Kap_12_Anvendelse_af_sentinel_node_06.02.13.pdf
15. Pavlou F. Where is the next generation of pathologists? The Pathologist. 2014.
16. Khoo JJ, Ng CS, Sabaratnam S, Arulanantham S et al. Sentinel node biopsy examination for breast cancer in a routine laboratory practice: results of a pilot study. Asian Pacific J. Cancer Prev. 2016; 17; 1149–1155.
17. Krogerus LA, Leidenius MH, Toivonen TS, von Smitten KJ et al. Towards reasonable workload in diagnosis of sentinel lymph nodes: comparison of two frozen section methods. Histopathology 2004; 44; 29–34.
18. DBCG. Aarsrapport 2015 (Danish). 2015. Available at: http://www.dbcg.dk/PDF%20Filer/aarsrapport2015_final_jan17.pdf
19. Carter BA, Page DL. Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact. J. Clin. Oncol. 2006; 24; 1978–1979.